October 20, 2020 : Issue #1073

TOP STORIES — Diabetes News and Research

The VERTIS CV Study – SGLT-2 Inhibitors’ Cardiovascular and Renal Outcomes in T2D

Telehealth, Smartphones, Mobile Apps and CGM: Changing the Way We Control Type 2 Diabetes In Adults

Elevated HbA1c = CVD

MOST POPULAR ARTICLES OF THE MONTH

#1 Vitamin D Deficiency Linked to Painful Diabetic Neuropathy

#2 Pumping Up with Protein: Does This Work for Exercise and Health?

#3 Possible Link Connecting COVID-19 and New-Onset Diabetes

In our last newsletter, we discussed the burden that new technology can have on children, and how the extra stress of having information at our fingertips can be overwhelming.

This week, our intern from LECOM College of Pharmacy, Tarshay Boyd, takes a look at how coupling these devices with Telehealth can change the way we manage diabetes, and empower our patients to actually want to take care of their diabetes and related disease states.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

This article is part of a live interview with Dr. Engel, Associate Vice President, Cardiometabolic and Women’s Health, Merck Research Laboratories.

Can a virtual diabetes clinic (VDC) improve diabetes care? 

The study aimed to investigate whether testing HbA1c will improve cardiovascular disease risk assessment.